| Lastest Insider Transactions Of X4 Pharmaceuticals, Inc ( XFOR ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | President and CEO | 2024-11-15 | Sell | 31,897 | 0.39 | 12,583 | 2024-11-19 16:31:25 |
| XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | President and CEO | 2024-10-15 | Sell | 31,897 | 0.56 | 17,926 | 2024-10-16 16:54:43 |
| XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | Chief Financial Officer | 2024-10-04 | Sell | 230,645 | 0.55 | 126,901 | 2024-10-08 16:44:42 |
| XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Officer | 2024-10-04 | Sell | 11,127 | 0.58 | 6,506 | 2024-10-08 16:44:32 |
| XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | President and CEO | 2024-10-04 | Sell | 239,436 | 0.55 | 131,522 | 2024-10-08 16:44:23 |
| XFOR | X4 Pharmaceuticals, Inc | DiBiase Mary | Chief Operating Officer | 2024-10-04 | Sell | 67,695 | 0.57 | 38,329 | 2024-10-08 16:44:13 |
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | 2024-10-04 | Sell | 76,920 | 0.56 | 43,306 | 2024-10-08 16:44:02 |
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | 2024-03-11 | Sell | 14,235 | 0.88 | 12,552 | 2024-03-11 17:20:25 |
| XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | President and CEO | 2024-03-11 | Sell | 49,678 | 0.88 | 43,856 | 2024-03-11 17:20:09 |
| XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | Chief Financial Officer | 2024-03-11 | Sell | 52,500 | 0.88 | 46,347 | 2024-03-11 17:19:52 |
| XFOR | X4 Pharmaceuticals, Inc | DiBiase Mary | Chief Operating Officer | 2024-03-11 | Sell | 15,409 | 0.88 | 13,591 | 2024-03-11 17:19:38 |
| XFOR | X4 Pharmaceuticals, Inc | DiBiase Mary | Chief Operating Officer | 2024-02-12 | Sell | 3,683 | 1.01 | 3,709 | 2024-02-12 17:23:55 |
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | 2024-02-12 | Sell | 787 | 1.01 | 793 | 2024-02-12 17:23:28 |
| XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | President and CEO | 2024-02-12 | Sell | 21,695 | 1.01 | 21,892 | 2024-02-12 17:05:01 |
| XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | Chief Financial Officer | 2024-02-12 | Sell | 27,721 | 1.01 | 27,973 | 2024-02-12 17:03:58 |
| XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | President and CEO | 2023-11-01 | Sell | 239,437 | 0.76 | 181,573 | 2023-11-03 17:26:49 |
| XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | Chief Financial Officer | 2023-11-01 | Sell | 230,645 | 0.73 | 168,371 | 2023-11-03 16:42:15 |
| XFOR | X4 Pharmaceuticals, Inc | DiBiase Mary | Chief Operating Officer | 2023-11-01 | Sell | 67,695 | 0.73 | 49,417 | 2023-11-03 16:40:51 |
| XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Officer | 2023-11-01 | Sell | 10,257 | 0.73 | 7,488 | 2023-11-03 16:39:45 |
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | 2023-11-01 | Sell | 67,695 | 0.73 | 49,417 | 2023-11-03 16:39:14 |
| XFOR | X4 Pharmaceuticals, Inc | DiBiase Mary | Chief Operating Officer | 2023-09-08 | Sell | 2,642 | 1.25 | 3,300 | 2023-09-12 16:04:56 |
| XFOR | X4 Pharmaceuticals, Inc | WYZGA MICHAEL S | Directior | 2023-08-18 | Buy | 25,000 | 1.20 | 29,875 | 2023-08-22 16:09:35 |
| XFOR | X4 Pharmaceuticals, Inc | Stewart Murray | Interim Chief Medical Officer | 2023-08-09 | Sell | 130,056 | 1.06 | 137,859 | 2023-08-11 19:26:20 |
| XFOR | X4 Pharmaceuticals, Inc | DiBiase Mary | Chief Operating Officer | 2023-06-23 | Sell | 857 | 1.93 | 1,654 | 2023-06-26 16:15:35 |
| XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | Chief Financial Officer | 2023-06-23 | Sell | 5,417 | 1.93 | 10,455 | 2023-06-26 16:13:24 |
| XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | President and CEO | 2023-06-23 | Sell | 6,724 | 1.92 | 12,910 | 2023-06-26 16:11:01 |
| XFOR | X4 Pharmaceuticals, Inc | DiBiase Mary | Chief Operating Officer | 2023-06-15 | Sell | 857 | 2.23 | 1,911 | 2023-06-16 16:24:23 |
| XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | Chief Financial Officer | 2023-06-15 | Sell | 5,417 | 2.22 | 12,026 | 2023-06-16 16:17:14 |
| XFOR | X4 Pharmaceuticals, Inc | DiBiase Mary | Chief Operating Officer | 2023-03-10 | Sell | 18,192 | 0.84 | 15,281 | 2023-03-13 16:52:32 |
| XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | Chief Financial Officer | 2023-03-10 | Sell | 52,500 | 0.84 | 44,100 | 2023-03-13 16:50:56 |
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | 2023-03-10 | Sell | 16,806 | 0.84 | 14,117 | 2023-03-13 16:48:46 |
| XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | President and CEO | 2023-03-10 | Sell | 49,678 | 0.84 | 41,730 | 2023-03-13 16:46:52 |
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | 2023-02-13 | Sell | 928 | 0.93 | 863 | 2023-02-15 17:13:39 |
| XFOR | X4 Pharmaceuticals, Inc | DiBiase Mary | Chief Operating Officer | 2023-02-13 | Sell | 4,348 | 0.93 | 4,044 | 2023-02-15 17:13:24 |
| XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | Chief Financial Officer | 2023-02-13 | Sell | 27,721 | 0.93 | 25,781 | 2023-02-15 17:12:45 |
| XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | President and CEO | 2023-02-13 | Sell | 21,695 | 0.93 | 20,176 | 2023-02-15 17:11:50 |
